1. Boothroyd C., Karia S., Andreadis N., Rombauts L., Johnson N., Chapman M., Australasian CREI Consensus Expert Panel on Trial evidence (ACCEPT) group. Consensus statement on prevention and detection of ovarian hyperstimulation syndrome. Aust N Z J Obstet Gynaecol. 2015;55(6):523–34. doi:10.1111/ ajo.12406.
2. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106(7):1634– 47. doi:10.1016/ j.fertnstert. 2016.08.048.
3. Royal College of Obstetricians and Gynaecologists. The Management of Ovarian Hyperstimulation Syndrome. Green-top Guideline No. 5. February 2016. 22 p.
4. Carter R., Petrie K., Sadighi A., Skene H. Ovarian hyperstimulation syndrome on the acute medical unit: a problem-based review. Acute Med. 2015;14(1):21–7.
5. Namavar Jahromi B., Parsanezhad M.E., Shomali Z., Bakhshai P., Alborzi M., Moin Vaziri N., Anvar Z. Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management. Iran J Med Sci. 2018;43(3):248–60.
6. Назаренко Т.А., Корнеева И.Е., Сароян T.T., Веряева Н.А. Спонтанный синдром гиперстимуляции яичников при одноплодной беременности. Проблемы репродукции. 2009;15(1):72–5.
7. Vasseur C., Rodien P., Beau I., Desroches A., Gérard C., de Poncheville L., Chaplot S., Savagner F., Croué A., Mathieu E., Lahlou N., Descamps P., Misrahi M. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med. 2003;349(8):753–9. doi:10.1056/NEJMoa030065.
8. Nelson S.M. Prevention and management of ovarian hyperstimulation syndrome. Thromb Res. 2017;151 Suppl:S61–4. doi:10.1016/S0049-3848(17)30070-1.
9. Corbett S., Shmorgun D., Claman P., REPRODUCTIVE ENDOCRINOLOGY INFERTILITY COMMITTEE, SPECIAL CONTRIBUTOR. The prevention of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can. 2014;36(11):1024–33. doi:10.1016/S1701-2163(15)30417-5.
10. Ironside E.C., Hotchen A.J. Ovarian hyperstimulation syndrome, the master of disguise? Case Rep Emerg Med. 2015;2015:510815. doi:10.1155/2015/510815.
11. Sousa M., Cunha M., Teixeira da Silva J., Oliveira C., Silva J., Viana P., Barros A. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Reprod Biol Endocrinol. 2015;13:66. doi:10.1186/s12958-0150067-3.
12. Lamazou F., Legouez A., Letouzey V., Grynberg M., Deffieux X., Trichot C., Fernandez H., Frydman R. [Ovarian hyperstimulation syndrome: pathophysiology, risk factors, prevention, diagnosis and treatment]. J Gynecol Obstet Biol Reprod (Paris). 2011;40(7):593–611. doi:10.1016/j.jgyn.2011.06.008.
13. Wei L.-H., Chou C.-H., Chen M.-W., Rose-John S., Kuo M.-L., Chen S.-U., Yang Y.-S. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model. J Clin Endocrinol Metab. 2013;98(3):E472-84. doi:10.1210/jc.2012-3462.
14. Сухих Г.Т., Сароян Т.Т., Корнеева И.Е. Иммунные аспекты патофизиологии синдрома гиперстимуляции яичников. Акушерство и гинекология. 2009;(3):3–6.
15. Retraction Note: Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intensive Care Med. 2011;37(7):1231. doi:10.1007/s00134-011-2218-0.
16. Daelemans C., Smits G., de Maertelaer V., Costagliola S., Englert Y., Vassart G., Delbaere A. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab. 2004;89(12):6310–5. doi:10.1210/ jc.2004-1044.
17. Topdagi Yilmaz E.P., Yapca O.E., Topdagi Y.E., Kaya Topdagi S., Kumtepe Y. Spontaneous Ovarian Hyperstimulation Syndrome with FSH Receptor Gene Mutation: Two Rare Case Reports. Case Rep Obstet Gynecol. 2018;2018:1–5.
doi:10.1155/2018/9294650.
18. Tan B.K., Mathur R. Management of ovarian hyperstimulation syndrome. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb). 2013;16(3):151–9. doi:10.3109/14647273.2013.788313.
19. Youssef M.A., Mourad S. Volume expanders for the prevention of ovarian hyperstimulation syndrome. Cochrane database Syst Rev. 2016;(8):CD001302.
doi:10.1002/14651858.CD001302.pub3.
20. Grossman L.C., Michalakis K.G., Browne H., Payson M.D., Segars J.H. The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertil Steril. 2010;94(4):1392–8. doi:10.1016/j. fertnstert.2009.07.1662.
21. Chun R., Kirkpatrick A.W. Intra-abdominal pressure, intra-abdominal hypertension, and pregnancy: a review. Ann Intensive Care. 2012;2 Suppl 1:S5. doi:10.1186/2110-5820-2-S1-S5.
22. Veisi F., Zangeneh M., Malekkhosravi S., Rezavand N. Abdominal Compartment Syndrome Due to OHSS. J Obstet Gynaecol India. 2013;63(5):350– 3. doi:10.1007/s13224-013-0480-5.
23. Makino H., Furui T., Shiga T., Takenaka M., Terazawa K., Morishige K.-I. Management of ovarian hyperstimulation syndrome with abdominal compartment syndrome, based on intravesical pressure measurement. Reprod Med Biol. 2017;16(1):72–6. doi:10.1002/rmb2.12005.
24. Malbrain M., De Waele J. Intra-Abdominal Hypertension. Cambridge: Cambridge University Press; 2013. doi:10.1017/CBO9780511667015.
25. Maslovitz S., Jaffa A., Eytan O., Wolman I., Many A., Lessing J.B., Gamzu R. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Obstet Gynecol. 2004;104(2):321–6. doi:10.1097/01. AOG.0000129956.97012.0d.
26. Sugrue M., Hallal A., D’Amours S. Intra-abdominal pressure hypertension and the kidney. In: Ivatury R, Cheatham M, Malbrain M, Sugrue M, editors. Abdominal Compartment Syndrome. Georgetown: Landes Bioscience; 2006. p. 119–28.